Knowledge Center

Poster / Nov 13, 2016

Aerodynamic Performance of DPIs versus Process Efficiency

Authors:
  • Filipa Maia
  • Maria Palha
  • Isabel Lopes
  • Filipe Neves
Source:
AAPS 2016

Dry powder inhalers target optimal performance, but should also consider the robustness of the downstream processes. Blend compositions which improve Fine Particle Fraction (FPF5μ³¾/·¡¶Ù) hinder process yield (rejection rate, RR) and device performance (emitted dose, ED). This work establishes relationships between blend rheology, product performance and downstream process efficiency and sets a Design Space which integrates different trade-offs between Product and Process optimization.

Related links

Also in the Knowledge Center

Related Content

Financial Stability

ËÄÉ«AV is a well established and financially stable company

Page
Read more

Devices

ËÄÉ«AV offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.

Page
Read more

Continuous Tableting for Drug Product

ËÄÉ«AV´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more